Literature DB >> 28241217

Medicare Part D Plans' Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease.

Chien-Wen Tseng1, Jinoos Yazdany2, R Adams Dudley2, Colette DeJong2, Dhruv S Kazi3, Randi Chen4, Grace A Lin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28241217      PMCID： PMC6822611          DOI： 10.1001/jamainternmed.2016.9386

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

1.  Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020.

Authors:  Earl S Ford; Louise B Murphy; Olga Khavjou; Wayne H Giles; James B Holt; Janet B Croft
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

2.  The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma.

Authors:  Anupam B Jena; Oliver Ho; Dana P Goldman; Pinar Karaca-Mandic
Journal:  JAMA Intern Med       Date:  2015-07       Impact factor: 21.873

3.  Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011.

Authors:  Earl S Ford
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

4.  Inhaler costs and medication nonadherence among seniors with chronic pulmonary disease.

Authors:  Peter J Castaldi; William H Rogers; Dana Gelb Safran; Ira B Wilson
Journal:  Chest       Date:  2010-04-23       Impact factor: 9.410

Review 5.  Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective.

Authors:  MeiLan K Han; Carlos H Martinez; David H Au; Jean Bourbeau; Cynthia M Boyd; Richard Branson; Gerard J Criner; Ravi Kalhan; Thomas J Kallstrom; Angela King; Jerry A Krishnan; Suzanne C Lareau; Todd A Lee; Kathleen Lindell; David M Mannino; Fernando J Martinez; Catherine Meldrum; Valerie G Press; Byron Thomashow; Laura Tycon; Jamie Lamson Sullivan; John Walsh; Kevin C Wilson; Jean Wright; Barbara Yawn; Patrick M Zueger; Surya P Bhatt; Mark T Dransfield
Journal:  Lancet Respir Med       Date:  2016-05-13       Impact factor: 30.700
  5 in total
  7 in total

1.  Effects of health literacy and cognitive abilities on COPD self-management behaviors: A prospective cohort study.

Authors:  Rachel O'Conor; Kimberly Muellers; Marina Arvanitis; Daniel P Vicencio; Michael S Wolf; Juan P Wisnivesky; Alex D Federman
Journal:  Respir Med       Date:  2019-02-14       Impact factor: 3.415

2.  Housing and Food Insecurity, Care Access, and Health Status Among the Chronically Ill: An Analysis of the Behavioral Risk Factor Surveillance System.

Authors:  Paniz Charkhchi; Soudabeh Fazeli Dehkordy; Ruth C Carlos
Journal:  J Gen Intern Med       Date:  2018-01-03       Impact factor: 5.128

Review 3.  Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products.

Authors:  Bryan Newman; Kimberly Witzmann
Journal:  Pharmaceut Med       Date:  2020-04

4.  Prescribing Patterns for Long-Acting Inhaled Bronchodilators Among Rural Adults With Chronic Obstructive Pulmonary Disease.

Authors:  Wendy M Brunner; Nadir Siddiqui; Melissa B Scribani; Nicole L Krupa; Erik Riesenfeld
Journal:  J Clin Med Res       Date:  2022-09-29

5.  Coverage of New Drugs in Medicare Part D.

Authors:  Huseyin Naci; Ilias Kyriopoulos; William B Feldman; Thomas J Hwang; Aaron S Kesselheim; Amitabh Chandra
Journal:  Milbank Q       Date:  2022-05-03       Impact factor: 6.237

6.  A Pilot Program to Teach Pharmacy Students Practical Skills to Navigate Drug Insurance Benefits.

Authors:  Camlyn Masuda; Tony Huynh; Veronica Wong; Colette DeJong; Chien-Wen Tseng
Journal:  Pharmacy (Basel)       Date:  2022-01-27

7.  Medication Cost-Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) Drug Products in the USA.

Authors:  Zhong Wang; Sharon K Ahluwalia; Bryan Newman; Sneha Dhapare; Liang Zhao; Markham C Luke
Journal:  Ther Innov Regul Sci       Date:  2022-02-03       Impact factor: 1.337
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.